Artificial Intelligence Offers Hope To Children With Rare Diseases

Artificial Intelligence Offers Hope To Children With Rare Diseases

“Insilico Medicine a leader in artificial intelligence for drug discovery, biomarker development and aging research, announced a research collaboration agreement with A2A Pharmaceuticals, Inc. A2A is a biotechnology company headquartered in New York and focused on development of novel drugs for unmet needs in oncology, drug resistant bacterial infections, and other life threatening diseases…”

https://www.mdtmag.com/news/2018/07/artificial-intelligence-offers-hope-children-rare-diseases

#future = #REALnews #health #medicine #medtech #wellness #tech #innovation #science #design #biotech #biology #xMed #singularity #engineering #ai #artificialintelligence #robots #automation